Showing results (61-70 of 113) with videos related to
Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|October 30, 2013
Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401Koichi Takayama, Koji Inoue, Shoji Tokunaga, et al.Anticancer Research|December 27, 2017
Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal CancerYuji Miyamoto, Eiji Oki, Yasunori Emi, et al.Journal of Clinical Medicine|December 18, 2019
Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer: LOGIK0408Koichi Takayama, Junji Uchino, Masaki Fujita, et al.The Oncologist|May 10, 2020
Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801Koichi Takayama, Masafumi Takeshita, Koji Inoue, et al.Clinical Lung Cancer|September 30, 2018
A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non-small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L)Hiroaki Akamatsu, Hideyuki Harada, Shoji Tokunaga, et al.Cancer Science|December 5, 2025
Effectiveness and Safety of Radium-223 for Bone-Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 StudyMasaki Shiota, Shuichi Tatarano, Tomomi Kamba, et al.Surgery|July 24, 2013
MAL2 expression predicts distant metastasis and short survival in pancreatic cancerDaiki Eguchi, Kenoki Ohuchida, Shingo Kozono, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2021
Gefitinib With Concurrent Thoracic Radiotherapy in Unresectable Locally Advanced NSCLC With EGFR Mutation; West Japan Oncology Group 6911LHiroaki Akamatsu, Haruyasu Murakami, Hideyuki Harada, et al.BMC Cancer|December 5, 2020
A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 studyTomoshi Tsuchiya, Ryotaro Kamohara, Masashi Muraoka, et al.Oncology|February 9, 2013
Phase II trial of alternating mFOLFOX6 and FOLFIRI regimens in the first-line treatment for unresectable or metastatic colorectal cancer (KSCC0701)Eiji Oki, Yasunori Emi, Yoshito Akagi, et al.Pageof 12